SINGAPORE: Singapore's supplies of COVID-19 antigen rapid self-test (ART) kits under two brands - SD Biosensor and Flowflex - are not affected by the US health authorities' advisory on the ...

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

There are two Flowflex at-home COVID-19 tests mentioned in the FDA warning, but one is not authorized in the U.S. Here's how to tell the difference.

Previously, the test was authorized for emergency use in 2021. The Flowflex COVID-19 Antigen Home Test is a nasal swab test for at-home use by symptomatic individuals within 6 days of symptom onset.